[1]董宏强,冯 杰,袁乃荣.温肺化饮汤治疗慢性阻塞性肺疾病急性加重期疗效及对患者气道重塑和CTRP-4、CTRP-5水平的影响[J].陕西中医,2024,(10):1365-1368.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.015]
　DONG Hongqiang,FENG Jie,YUAN Nairong.Efficacy of Wenfei Huayin decoction on AECOPD and influence on airway remodeling and CTRP-4 and CTRP-5 levels[J].,2024,(10):1365-1368.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.015]
点击复制

温肺化饮汤治疗慢性阻塞性肺疾病急性加重期疗效及对患者气道重塑和CTRP-4、CTRP-5水平的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1365-1368
栏目:
临床研究
出版日期:
2024-10-05

文章信息/Info

Title:
Efficacy of Wenfei Huayin decoction on AECOPD and influence on airway remodeling and CTRP-4 and CTRP-5 levels
作者:
董宏强1; 冯 杰2; 袁乃荣1
(1.山西省人民医院中医科,山西 太原 030012; 2.太原市中医医院妇科,山西 太原 030009)
Author(s):
DONG Hongqiang; FENG Jie; YUAN Nairong
(Department of Traditional Chinese Medicine,Shanxi Provincial People's Hospital,Taiyuan 030012,China)
关键词:
慢性阻塞性肺疾病;  寒饮停肺型;  温肺化饮汤;  气道重塑;  补体C1q肿瘤坏死因子相关蛋白;  中医症候积分;  神经生长因子
Keywords:
Chronic obstructive pulmonary disease;  Cold fluid retention in the lung type;  Wenfei Huayin decoction;  Airway remodeling;  Complement C1q tumor necrosis factor-related protein;  TCM symptoms scores;  Nerve growth factor
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7369.2024.10.015
文献标志码:
A
摘要:
目的:探究温肺化饮汤治疗寒饮停肺型慢性阻塞性肺疾病急性加重期(AECOPD)的疗效,并分析其对患者气道重塑指标及血清补体C1q肿瘤坏死因子相关蛋白-4(CTRP-4)、CTRP-5水平的影响。方法:将102例AECOPD患者随机分为两组。对照组51例予以常规西药治疗,观察组51例在此基础上加服温肺化饮汤。评价两组患者临床疗效及中医症候积分,比较两组治疗前后的气道重塑指标[基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)、神经生长因子(NGF)]及CTRP-4、CTRP-5水平,观察两组的不良反应情况。结果:观察组的临床疗效高于对照组(P<0.05); 相较于对照组,观察组治疗后的各中医症候积分降低(P<0.05); 与对照组比较,观察组治疗后的血清MMP-2、MMP-9、NGF、CTRP-4、CTRP-5水平均降低(P<0.05); 两组不良反应情况组间比较差异无统计学意义(P>0.05)。结论:温肺化饮汤治疗寒饮停肺型AECOPD患者的疗效显著,可有效缓解临床症状,并可通过调节气道重塑指标及CTRP-4、CTRP-5水平发挥作用。
Abstract:
Objective:To explore the efficacy of Wenfei Huayin decoction in the treatment of cold fluid retention in the lung type of acute exacerbation of chronic obstructive pulmonary disease(AECOPD),and to analyze its influence on airway remodeling indexes,serum complement C1q tumor necrosis factor-related protein-4(CTRP-4)and CTRP-5 levels.Methods:Totally 102 patients with AECOPD were randomized into two groups.51 cases in the control group were treated with conventional western medicine,while 51 cases in the observation group were added with Wenfei Huayin decoction on this basis.The clinical efficacy and TCM symptoms scores were evaluated in the two groups.The airway remodeling indexes [matrix metalloproteinase-2(MMP-2),matrix metalloproteinase-9(MMP-9),nerve growth factor(NGF)],CTRP-4 and CTRP-5 were compared before and after treatment,and the adverse reactions were observed.Results:The observation group had higher clinical efficacy(P<0.05).The scores of TCM symptoms were decreased in the observation group after treatment(P<0.05).In the observation group,serum levels of MMP-2,MMP-9,NGF,CTRP-4 and CTRP-5 after treatment were declined compared to the control group(P<0.05).There were no obvious differences in adverse reactions between groups(P>0.05).Conclusion:Wenfei Huayin decoction is effective in the treatment of AECOPD of cold fluid retention in the lung.It can effectively relieve clinical symptoms and play a role by regulating airway remodeling indexes and CTRP-4 and CTRP-5 levels.

参考文献/References:

[1] DI J,LI X,XIE Y,et al.Procalcitonin-guided antibiotic therapy in AECOPD patients:Overview of systematic reviews[J].Clin Respir J,2021,15(6):579-594.
[2] 周旭东,吴吉星,夏杰.慢性阻塞性肺疾病患者急性加重影响因素及血清分泌型卷曲相关蛋白1和Clara细胞分泌蛋白对其预测价值[J].陕西医学杂志,2023,52(9):1168-1171,1176.
[3] 沈科,张子洲,钱璞,等.气道激素雾化吸入联合前列地尔治疗老年AECOPD合并肺动脉高压患者的临床研究[J].中国临床药理学杂志,2023,39(16):2283-2287.
[4] 刘圣金,马瑜璐,房方,等.矿物药青礞石对慢性阻塞性肺疾病急性加重期(AECOPD)大鼠肺组织代谢组学研究[J].中国中药杂志,2021,46(12):3133-3143.
[5] 张晓琴.布地奈德联合特布他林雾化吸入治疗AECOPD个性化护理的应用价值分析[J].重庆医学,2019,48(2):199-201.
[6] 陈威,欧阳国林,冯原.苓桂三子汤联合雷火灸治疗痰湿阻肺型AECOPD的临床疗效观察[J].重庆医学,2023,52(24):3760-3764.
[7] 胡阳春,李瑾,董璐怡.桑白皮汤加减治疗痰热郁肺证AECOPD疗效及对患者中医证候积分、血清CCL-18、MMP-9水平的影响[J].辽宁中医杂志,2023,50(10):96-99.
[8] 屈蕾蕾,张衡中,杨瑞,等.温肺散寒涤饮汤联合膀胱经姜疗法治疗慢性阻塞性肺疾病急性加重期临床研究[J].新中医,2019,51(10):103-106.
[9] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性阻塞性肺疾病基层诊疗指南(2018年)[J].中华全科医师杂志,2018,17(11):856-870.
[10] 中华中医药学会内科分会肺系病专业委员会.慢性阻塞性肺疾病中医诊疗指南(2011版)[J].中医杂志,2012,53(1):80-84.
[11] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:243.
[12] LI J,LIANG L,FENG L,et al.The prognostic value of blood eosinophil level in AECOPD is influenced by corticosteroid treatment during hospitalization[J].J Inflamm Res,2023,16:3233-3243.
[13] CHEN H,ZHOU H,LUO C,et al.Efficacy of treatment with N-acetylcysteine inhalation for AECOPD:A propensity-score-matched cohort study[J].Clin Respir J,2023,17(10):1038-1047.
[14] 刘敬敬,程玉峰,崔磊.化痰止咳平喘汤联合布地奈德治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2024,45(2):204-207.
[15] 杨诚.清肺化痰汤合桑白皮汤治疗慢性阻塞性肺疾病急性加重期痰热壅肺证疗效及对患者免疫功能的影响[J].陕西中医,2021,42(9):1223-1225.
[16] 姚梦雪,冉姗,孙方方,等.基于GC-MS代谢组学姜炮制-配伍治疗寒饮伏肺哮喘大鼠的作用机制研究[J].中草药,2020,51(3):669-681.
[17] 刘智霖,史利卿,马建岭,等.难治性慢性咳嗽的“多维度病机”认识与证治浅探[J].北京中医药大学学报,2022,45(5):507-512.
[18] 许世英,孙文才,郝秀珍,等.苏子降气汤合苓甘五味姜辛汤加减辅助西药治疗寒饮伏肺型慢性阻塞性肺疾病急性加重期的疗效观察[J].中国医院用药评价与分析,2019,19(7):791-794.
[19] 孙安兵,杨殿福,户晓艳.物理康复联合小青龙汤治疗儿童哮喘缓解期肺脾气虚证的效果[J].西安交通大学学报(医学版),2023,44(1):142-146.
[20] 韩慧,徐平,宋卫东.慢性阻塞性肺疾病患者气道炎症反应、肺功能与生化指标相关性研究[J].陕西医学杂志,2023,52(10):1358-1361,1366.
[21] 张胜碧,刘燕玲,李岚.地龙提取液对卵清蛋白诱导哮喘小鼠气道重塑及肺组织MMP2、MMP9、TIMP-1表达的影响[J].中国新药与临床杂志,2021,40(7):523-530.
[22] 佘巍巍,孙天寿,吴娟,等.肺内靶向吸入NGF抗体抑制小鼠体内NGF及TGF-β1改善哮喘气道重塑的作用机制[J].中国老年学杂志,2021,41(5):1063-1067.
[23] 韩静,刘晓宇,翁军,等.慢性阻塞性肺疾病急性加重期患者血清CTRP-5、FKN水平变化及其临床意义[J].山东医药,2020,60(34):15-19.
[24] 陈艳蓉,石赟,王珊,等.老年慢性阻塞性肺疾病急性加重期患者血清CTRP-4、CTRP-6、CTRP-9与肺功能和炎症因子的相关性分析[J].现代生物医学进展,2023,23(10):1857-1861.
[25] 万浩宇,张璐,万海同,等.基于p38MAPK/NF-κB信号通路的麻黄汤抗哮喘作用机制研究[J].中国药理学通报,2021,37(3):423-429.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(10):610.
[3]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(10):995.
[4]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(10):1491.
[5]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(10):57.
[6]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(10):180.
[7]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[8]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(10):534.
[9]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
　TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(10):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
[10]蔡东林,孙钟和,赵益庆.慢性阻塞性肺疾病稳定期BODE指数、IL-8、TNF-α水平与肺肾气虚证相关性研究*[J].陕西中医,2020,(11):1573.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.015]

备注/Memo

备注/Memo:
基金项目:山西省重点研发计划项目(201903D321238)
更新日期/Last Update: 2024-10-08